Clinical Trial Update: ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluated the pharmacokinetics of ch14.18 (dinutuximab) in high-risk neuroblastoma in Phase 1/Phase 2. The study is completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• UNITUXIN (dinutuximab)

Snippet

Sponsor: United Therapeutics | Conditions: Neuroblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-09-23